Pharmacokinetic/pharmacodynamic analysis as a tool for surveillance of the activity of antimicrobials against Pseudomonas aeruginosa strains isolated in critically ill patients-Reference-Cited by-同舟云学术

Pharmacokinetic/pharmacodynamic analysis as a tool for surveillance of the activity of antimicrobials against Pseudomonas aeruginosa strains isolated in critically ill patients

Published:2019-06 Issue:6 Volume:37 Page:380-386
ISSN:0213-005X
Container-title:Enfermedades Infecciosas y Microbiología Clínica
language:en
Short-container-title:Enfermedades Infecciosas y Microbiología Clínica

Author:

Valero Ana,Isla Arantxa,Rodríguez-Gascón Alicia,Calvo Begoña,Canut Andrés,Solinís María Ángeles

Funder

Universia Foundation

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference30 articles.

1. ICON investigators assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit;Vincent;Lancet Respir Med,2014

2. EPIC II Group of Investigators International study of the prevalence and outcomes of infection in intensive care units;Vincent;JAMA,2009

3. Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa;Kollef;Crit Care Med,2014

4. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa;Bonomo;Clin Infect Dis,2006

5. Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection;DiMondi;Int J Clin Pharm,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach;Antibiotics;2024-06-13

2. Mechanism of PK/PD-based Combination of Biapenem and Other Antibiotics on Antibacterial Activity of Pseudomonas aeruginosa in Vitro;J BIOL REG HOMEOS AG;2024

3. Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?;Pharmaceutics;2023-04-07

4. Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability;Antibiotics;2022-05-11

5. Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis;Pharmaceutics;2021-11-08